ITF Therapeutics Reveals Multiple Data At 2026 MDA Conference
23 Feb 2026 //
PR NEWSWIRE
Givinostat Data Revealed For Duchenne Muscular Dystrophy At 2025
26 Sep 2025 //
PR NEWSWIRE
ITF Therapeutics Publishes Positive Long-Term Data on Givinostat
25 Aug 2025 //
PR NEWSWIRE
ITF Therapeutics LLC Opens New U.S. HQ in Concord, Massachusetts
05 Mar 2025 //
PR NEWSWIRE

Market Place
Sourcing Support